The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Update with Provectus Biopharmaceuticals, Inc. - Discusses Clinical Developments for PV-10, Immunotherapy, Goals and Milestones

SNNLive caught up with Peter Culpepper, Interim CEO and COO of Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) at the Growth Capital Expo 2016 in Las Vegas, NV.

Share With

Tuesday, May 17, 2016

   

© 2017 Stock News Now